GITNUX MARKETDATA REPORT 2024

Neuropathic Pain Industry Statistics

The neuropathic pain industry is expected to experience steady growth due to the increasing prevalence of chronic pain conditions and the development of novel treatments.

Statistic 1

"The global neuropathic pain market is expected to reach USD 9.7 billion by 2024."

Sources Icon

Statistic 2

"The global market for neuropathic pain is predicted to grow at a CAGR of approximately 6.5% during the forecast period from 2019 to 2024."

Sources Icon

Statistic 3

"In 2019, the North America neuropathic pain market accounted for about 43% of global market share."

Sources Icon

Statistic 4

"The Asia-Pacific region is expected to witness the highest CAGR during the forecast period in the neuropathic pain market."

Sources Icon

Statistic 5

"The diabetic neuropathy segment is expected to hold a significant share in the market with a CAGR of 6.3% during the forecast period."

Sources Icon

Statistic 6

"Pfizer, Johnson & Johnson, and Eli Lilly are some of the major players in the neuropathic pain market."

Sources Icon

Statistic 7

"Lyrica (Pregabalin) and Neurontic (Gabapentin), drugs used to treat neuropathic pain, account for more than 50% of the global sales."

Sources Icon

Statistic 8

"The market for neuropathic pain treatment is projected to come close to USD 8.5 Bn by the end of 2025."

Sources Icon

Statistic 9

"Anticonvulsants are projected to account for the largest share in the global neuropathic pain market."

Sources Icon

Statistic 10

"Over-the-counter drugs segment holds the smallest market share in the global neuropathic pain market."

Sources Icon

Statistic 11

"Increasing funding in R&D for neuropathic pain treatment drugs is expected to drive significant market growth."

Sources Icon

Statistic 12

"The difficulty in diagnosing neuropathic pain is a major market restraint."

Sources Icon

Statistic 13

"The prevalence of neuropathic pain is estimated to be 3–17% of the population worldwide."

Sources Icon

Statistic 14

"Approximately 65-70% of individuals with diabetes suffer from diabetic neuropathy, a form of neuropathic pain."

Sources Icon

Statistic 15

"The number of people suffering from painful diabetic neuropathy in the United States is estimated to be between 600,000 and 3.6 million."

Sources Icon

Statistic 16

"Estimates suggest that worldwide almost 26 million people suffer from neuropathic pain due to spinal cord injury."

Sources Icon

Statistic 17

"It is estimated that 30% of neuropathic pain disorders are due to cancer treatments."

Sources Icon

Statistic 18

"The CDC estimates that about 20 million people in the U.S. have some form of peripheral neuropathy, a condition that often causes neuropathic pain."

Sources Icon

Statistic 19

"By 2080, the number of people with peripheral neuropathy (and likely neuropathic pain) is predicted to rise by almost 60%."

Sources Icon

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!